Kepler Cheuvreux Suisse SA Makes New Investment in Mettler-Toledo International, Inc. $MTD

Kepler Cheuvreux Suisse SA purchased a new stake in Mettler-Toledo International, Inc. (NYSE:MTDFree Report) in the 4th quarter, Holdings Channel.com reports. The fund purchased 786 shares of the medical instruments supplier’s stock, valued at approximately $1,096,000.

Other large investors also recently made changes to their positions in the company. Geneos Wealth Management Inc. lifted its position in Mettler-Toledo International by 83.3% during the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after buying an additional 30 shares during the period. Baird Financial Group Inc. boosted its stake in Mettler-Toledo International by 3.1% in the 2nd quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock worth $1,582,000 after buying an additional 40 shares during the last quarter. Jump Financial LLC increased its stake in shares of Mettler-Toledo International by 44.6% during the 2nd quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after acquiring an additional 125 shares during the last quarter. Cerity Partners LLC increased its stake in shares of Mettler-Toledo International by 10.8% during the 2nd quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock valued at $4,740,000 after acquiring an additional 392 shares during the last quarter. Finally, AXA S.A. lifted its holdings in shares of Mettler-Toledo International by 2.9% during the 2nd quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock worth $5,433,000 after acquiring an additional 131 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Down 3.8%

Shares of MTD opened at $1,081.27 on Tuesday. The firm has a market cap of $21.90 billion, a PE ratio of 25.36, a price-to-earnings-growth ratio of 2.36 and a beta of 1.31. The company’s fifty day moving average is $1,265.38 and its two-hundred day moving average is $1,363.86. Mettler-Toledo International, Inc. has a fifty-two week low of $1,078.44 and a fifty-two week high of $1,525.17.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share for the quarter, beating the consensus estimate of $8.70 by $0.21. The business had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The business’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 46.54 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts recently issued reports on MTD shares. Jefferies Financial Group raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and raised their target price for the stock from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Barclays decreased their price target on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a report on Tuesday, April 14th. Robert W. Baird decreased their price target on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday. JPMorgan Chase & Co. decreased their price target on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a report on Monday. Finally, Citigroup decreased their price target on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday. Seven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, Mettler-Toledo International has a consensus rating of “Moderate Buy” and an average price target of $1,437.00.

Check Out Our Latest Stock Analysis on MTD

Key Stories Impacting Mettler-Toledo International

Here are the key news stories impacting Mettler-Toledo International this week:

Mettler-Toledo International Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Featured Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.